A case of recurrent vulvar carcinoma treated with erlotinib, an EGFR inhibitor

European Journal of Gynaecological Oncology

Volumn 32, Issue 4, 2011, Pages 423-424

  Bacha, O M ^a   Levesque, E ^a   Renaud, M C ^a   Lalancette, M ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Epithelial growth factor receptor; Erlotinib; Tarceva; Vulvar carcinoma

Indexed keywords

ERLOTINIB;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG TOLERABILITY; FEMALE; HUMAN; LUNG METASTASIS; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; VULVA CARCINOMA; VULVA SQUAMOUS CELL CARCINOMA;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; FATAL OUTCOME; FEMALE; HUMANS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; VULVAR NEOPLASMS;

EID: 80052716029     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Gadducci A., Cionini L., Romanini A., Fanucchi A., Gennazzani A.R.: "Old and new perpectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer". Critical reviews in oncology/Hematology; 2006, 60, 227.
2. Olawaiye A., Lee L.M., Krasner C., Horowitz N.: "Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva". Gynecol. Oncol., 2007, 106, 628.
3. Johnson G.A., Mannel R., Khalifa M., Walker J.L., Wren M., Min K.W., Benbrook D.M.: "Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival". Gynecol. Oncol., 1997, 65, 425.
4. Richard S.D., Krivak T.C., Beriwal S., Zorn K.K.: "Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab". Int. J. Gynecol. Cancer, 2008, 18, 1132.